FILANA THERAPEUTICS, INC.
Pharmaceutical Preparations · AUSTIN · TX
Moderate confidence (50%)
Updated Oct 21, 2026, 12:03 AM
What is happening
Derived by rule set status-rules-2026.09.7
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.
Latest material event: FILANA THERAPEUTICS, INC. received a delisting notice from its exchange (Sep 17, 2026)
Timeline
Every material event, newest first. History is never overwritten.
FILANA THERAPEUTICS, INC. received a delisting notice from its exchange
Sep 17, 2026
Delisting notice received
- SEC EDGAR — “Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 17, 2026, Filana Therapeutics, Inc. (the Company ) received written notice (the Notice ) from the Nasdaq Stock Market, LLC ( Nasdaq ) indicating that the bid price for the Company s common stock (the Common Stock ), for the last thirty (30) consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price requirement for the continued listing on the Nasdaq Capital Market, as set fort…”
Company information
- Founded
- —
- Employees (estimate)
- —
- Industry
- Pharmaceutical Preparations
- Subindustry
- —
- Listing
- SEC lists the ticker FLNA on Nasdaq.
- SEC CIK
- 0001069530
- Website
- —
- —
- Headquarters
- AUSTIN, TX
- Also known as
- CASSAVA SCIENCES INC, PAIN THERAPEUTICS INC
- Legal entities
- FILANA THERAPEUTICS, INC.
Sources
Every material source used to build this profile.
SEC Company Submissions (TIER 1 · UNVERIFIED)
FILANA THERAPEUTICS, INC. — Pharmaceutical Preparations (SIC 2834) — AUSTIN, TX
View source recordSEC EDGAR (TIER 1 · UNVERIFIED)
Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing. On September 17, 2026, Filana Therapeutics, Inc. (the Company ) received written notice (the Notice ) from the Nasdaq Stock Market, LLC ( Nasdaq ) indicating that the bid price for the Company s common stock (the Common Stock ), for the last thirty (30) consecutive business days, had closed below the minimum $1.00 per share and, as a result, the Company is not in compliance with the $1.00 minimum bid price requirement for the continued listing on the Nasdaq Capital Market, as set fort…
View source record
Status history
Every derived status, with the rule that produced it.
- UNKNOWN → DISTRESS_SIGNALLISTING_STANDARDS_WARNING · Sep 20, 2026, 12:14 AM
An exchange warned the company it no longer meets the listing standards. Companies regain compliance often.